IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin

Norma Rallón, José M. Benito(Hospital Universitario Rey Juan Carlos), Susanna Naggie(Duke University), John G. McHutchison(Gilead Sciences (United States)), Eugenia Vispo, Vincent Soriano(Instituto de Salud Carlos III), Clara Restrepo, David B. Goldstein(Structural Genomics Consortium)
AIDS
April 19, 2011
10.1097/qad.0b013e3283471cae
Cited by 45

Related Papers

Genome-wide association studies for complex traits: consensus, uncertainty and challenges
|Nature Reviews Genetics|2008|3k
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
|Nature|2009|2.1k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
|New England Journal of Medicine|2014|1.1k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k